DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Child Mania Rating Scale-Parent Version: a valid measure of symptom change due to pharmacotherapy.

Author(s): West AE, Celio CI, Henry DB, Pavuluri MN

Affiliation(s): University of Illinois at Chicago, Chicago, IL 60608, United States. awest@psych.uic.edu

Publication date & source: 2011-01, J Affect Disord., 128(1-2):112-9. Epub 2010 Sep 21.

Publication type: Evaluation Studies; Research Support, N.I.H., Extramural; Validation Studies

BACKGROUND: The development of valid parent-report measures of symptom change in pediatric bipolar disorder (PBD) is imperative to evaluate the effectiveness of different treatment approaches; yet, few studies have tested the sensitivity of symptom measures. The current study evaluated the sensitivity of the Child Mania Rating Scale (CMRS-P) to detect symptom change over time in a treatment study for PBD. METHODS: Data on symptom change were drawn from a prospective six-week, double-blind, placebo-controlled, randomized outpatient medication treatment trial of risperidone versus divalproex. The sample included 66 children with Bipolar type I disorder. Measures were administered every week for six weeks of treatment. RESULTS: The CMRS-P demonstrated statistically (p </= .05) and clinically significant change in symptom report from pre to post-test. Growth curve modeling indicated that the CMRS-P demonstrated overall similarity to the YMRS in the magnitude and trajectory of change over time. Finally, results indicate that the CMRS-P is able to detect response rates with moderate levels of agreement with other measures. LIMITATIONS: Limitations of this study include a relatively small sample size and uncertain generalizability beyond treatment trials. CONCLUSIONS: The CMRS-P is short, easy to administer, and represents parent's report of symptoms, all strengths which make it a compelling treatment outcome tool. This preliminary evidence of its validity as a treatment outcome measure makes it applicable in other research settings and suggests its potential use in clinical settings. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017